Exeltis Italia

Exeltis Italia company information, Employees & Contact Information

Explore related pages

Related company profiles:

Exeltis è un’azienda farmaceutica parte della multinazionale spagnola Insud Pharma. Con una presenza internazionale in oltre 40 Paesi, un team di oltre 4.000 professionisti e una rete globale di produzione in Europa, America e Asia, Exeltis è leader nell’ambito della salute femminile. Si dedica, inoltre, allo sviluppo di soluzioni terapeutiche negli ambiti respiratorio, dermatologico e dell’oftalmologia. L’azienda gestisce un portfolio di oltre 300 farmaci e prodotti che arrivano a milioni di persone in tutto il mondo. Il settore su cui investe maggiormente è quello del benessere e della salute donna, in diverse aree terapeutiche: dalla salute riproduttiva alla contraccezione, dalla gravidanza al parto e alla menopausa. La filiale italiana di Exeltis nasce nel 2017 e, nel 2025, commercializza numerosi prodotti (farmaci, medical devices, integratori) su tutto il territorio nazionale, con l’obiettivo di migliorare la salute delle donne, nelle diverse fasi della loro vita.

Company Details

Employees
67
Founded
-
Address
Via Lombardia, 2 A, Peschiera Borromeo,italia 20068,italy
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
exeltis.it
HQ
Peschiera Borromeo, Italia
Looking for a particular Exeltis Italia employee's phone or email?

Exeltis Italia Questions

News

THX Pharma and Exeltis announce first milestone achieved for neurological disease treatment - Pharmafile

THX Pharma and Exeltis announce first milestone achieved for neurological disease treatment Pharmafile

Noninvasive blood test offers new diagnostic approach for endometriosis - Contemporary OB/GYN

Noninvasive blood test offers new diagnostic approach for endometriosis Contemporary OB/GYN

Afaxys and Exeltis Renew Partnership to Expand Access to Twirla® (levonorgestrel and ethinyl estradiol) Transdermal System - Yahoo Finance

Afaxys and Exeltis Renew Partnership to Expand Access to Twirla® (levonorgestrel and ethinyl estradiol) Transdermal System Yahoo Finance

Theranexus : THX PHARMA (THERANEXUS) AND EXELTIS ACHIEVE KEY MILESTONE TOWARDS THE COMMERCIALIZATION OF TX01 - MarketScreener

Theranexus : THX PHARMA (THERANEXUS) AND EXELTIS ACHIEVE KEY MILESTONE TOWARDS THE COMMERCIALIZATION OF TX01 MarketScreener

Theranexus leaps on deal with Exeltis to commercialize TX01 - The Pharma Letter

Theranexus leaps on deal with Exeltis to commercialize TX01 The Pharma Letter

Theranexus and Exeltis (Insud Pharma) Announce Licensing Agreement to Commercialize Theranexus Tx01 for Two Rare Neurological Disorders - Yahoo Finance

Theranexus and Exeltis (Insud Pharma) Announce Licensing Agreement to Commercialize Theranexus Tx01 for Two Rare Neurological Disorders Yahoo Finance

The Population Council’s Center for Biomedical Research Enters Agreement with Exeltis to Develop a Non-Hormonal Multipurpose Intravaginal Ring - Population Council

The Population Council’s Center for Biomedical Research Enters Agreement with Exeltis to Develop a Non-Hormonal Multipurpose Intravaginal Ring Population Council

Facebook post lands Exeltis in hot water - pharmaphorum

Facebook post lands Exeltis in hot water pharmaphorum

Lupin Infringes Exeltis Contraceptive Patents, Judge Finds - Law360

Lupin Infringes Exeltis Contraceptive Patents, Judge Finds Law360

Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L. - GlobeNewswire

Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L. GlobeNewswire

FDA blasts Exeltis over 'misleading' social media post about birth control drug - Fierce Pharma

FDA blasts Exeltis over 'misleading' social media post about birth control drug Fierce Pharma

Exeltis focuses on women’s health to grow in Brazil - Valor International

Exeltis focuses on women’s health to grow in Brazil Valor International

, a First-of-its-Kind Postpartum Mood Support Dietary Supplement* for New Mothers Experiencing Postpartum Blues - Business Wire

, a First-of-its-Kind Postpartum Mood Support Dietary Supplement* for New Mothers Experiencing Postpartum Blues Business Wire

Facebook post prompts untitled letter to birth control maker Exeltis - Regulatory Affairs Professionals Society | RAPS

Facebook post prompts untitled letter to birth control maker Exeltis Regulatory Affairs Professionals Society | RAPS

Lupin partners with Exeltis for marketing its specialty drug Solosec in US - The Economic Times

Lupin partners with Exeltis for marketing its specialty drug Solosec in US The Economic Times

FDA warns Exeltis over misleading advertising of Slynd birth control pill | World News - Hindustan Times

FDA warns Exeltis over misleading advertising of Slynd birth control pill | World News Hindustan Times

Exeltis USA, Inc. Sparks National Conversation About Health Equity, Inclusion and Body Positivity During Women’s Health Month with “Let’s Love Every Body” Campaign - Business Wire

Exeltis USA, Inc. Sparks National Conversation About Health Equity, Inclusion and Body Positivity During Women’s Health Month with “Let’s Love Every Body” Campaign Business Wire

Fertility Supplements Global Market Report 2024-2029, with - GlobeNewswire

Fertility Supplements Global Market Report 2024-2029, with GlobeNewswire

Top Exeltis Italia Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant